Structural Biology and Molecular Modeling Market Insights Forecast 2023-29

According to Precision Business Insights' (PBI) latest report the structural biology and molecular modeling market size was valued at USD 7,891.2 million in 2022 and is poised to grow at a significant CAGR of 16.3% during the forecast period 2023-2029. Chronic diseases like diabetes, cancer, and heart disease are on the rise in developed countries due to the ageing populations. The medical and healthcare industries benefit from structural biology and molecular modelling because they help in the search for treatments for a variety of illnesses.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/structural-biology-and-molecular-modeling-market

The global structural biology and molecular modeling market segmentation:
1) By Tools: SaaS and Standalone Modeling, Visualization and Analysis, and Other Tools
2) By Application: Drug Development, Drug Discovery, and Other Applications.

SaaS & standalone modeling Segment Dominate The Structural Biology and Molecular Modeling Market:
SaaS& standalone modelling segment accounted for highest market share, and it is expected to grow with a CAGR from 2023-2029. Monoclonal Antibody (mAb) segment is expected to grow drastically due to the fact that increasing use of software to study and analyze the structure of the molecules to see the reaction etc. Also, the computer-aided predictive procedure in structural biology would also propel this market.

North America leads Structural Biology and Molecular Modeling Market.
In the north, the Structural Biology and Molecular Modelling market holds a highest market share in 2022 and the market is expected to grow at a significant CAGR during the forecast period. Due to various ongoing research in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of structural biology and molecular modeling techniques in the market.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=185130

Strategic New Product Lafor Lunches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The structural biology and molecular modeling market further reveals that the key players increasingly adopting strategies such as the launch of newer products, frequent product approvals, and long-term alliances to improve market revenue share and gaining significant geographic presence across the region. In March 2022, PerkinElmer introduced Chem Draw V21 software, which allows researchers to construct chemically intelligent Microsoft PowerPoint presentations with a single click.

The key players in the structural biology and molecular modeling market report are Acellera Ltd, Agile Molecule, Agilent Technologies Inc., Biomax Informatics AG, Bruker Daltonics Inc., Chemical Computing Group, Dassault Systemes, Illumina, ThermoFisher Scientific, CD BioSciences, Charles River Technologies, Horiba.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.